The Primate Corticospinal Connectome and Transcriptome
The Primate Corticospinal Connectome and Transcriptome
批准号:
10650134
负责人:
MARK H. TUSZYNSKI
金额:
$63.09万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-15 至 2026-05-31
关键词:
AdultAffinity ChromatographyAxonBrainCellsCervical spinal cord structureCorticospinal TractsDataDistalEmbryoGenesGenetic TranscriptionGrantGrowthHandHumanInjuryInterneuronsInterventionKnowledgeLabelLesionMacaca mulattaMonkeysMotorMotor CortexMotor NeuronsMusNatural regenerationNatureNeuronsPathway interactionsPrimatesPropertyRattusRecovery SupportRecovery of FunctionReportingRiboTagRibosomesRodentSeriesSiteSpinal CordSpinal cord injurySynapsesSystemTherapeutic InterventionTimeTranslationsUp-RegulationViralViral VectorWorkaxon injuryaxon regenerationcell typeconnectomecritical periodfunctional improvementimprovedinjuredmotor controlnerve stem cellneuralneural graftnovelprogramsregenerativesevere injurystem cellstime usetranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Efforts to promote recovery of function after human spinal cord injury (SCI) will likely require interventions
targeting the corticospinal motor system, the most important pathway for voluntary motor control in
humans. In a series of studies over the past 4 years we have found that corticospinal tract (CST) axons
regenerate into spinal cord neural stem cell (NSC) grafts placed into sites of SCI in mice, rats and
monkeys. These regenerating CST axons form synapses with the graft, and the graft in turn extends very
large numbers of new axons from the injury site over long distances into the distal spinal cord. Neural
relays across the injury are thereby formed, supporting functional improvement. This work is on a human
translational path and IND-enabling work is in progress.
This grant proposes two new directions that will be critically important in supporting human translation.
First, we recently reported that injured adult mouse CST neurons revert to an embryonic transcriptional
state that lasts for two weeks after SCI, a time during which CST axons can regenerate. This finding
establishes a critical period for intervention after mouse SCI to support recovery. Does the same
transcriptional reversion to a pro-growth embryonic state occur in the primate brain? If so, how long does
it last? Work in Aim 1 will definitively answer this question, identifying for the first time what may be an
optimal time window for therapeutic intervention of any type to support functional recovery in primates,
including humans. We will perform RNA sequencing (RNAseq) specifically of CST neurons after SCI in
rhesus monkeys using intersectional viral approaches, based on supportive preliminary data in monkeys.
In Aim 2 we propose for the first time using novel viral vectors to anterogradely, trans-synaptically trace
primate corticospinal projections to the spinal cord. Our preliminary studies demonstrate that rodent CST
axons project nearly entirely to spinal cord interneurons, whereas in primates the vast preponderance of
CST axons terminate directly on alpha motor neurons. Knowing the precise targets of CST projections to
the spinal cord will both markedly extend our basic knowledge of motor system organization in primates,
and will allow optimization of stem cell graft properties to enhance neural relay formation across sites of
SCI. Unlike other neural stem cell programs for SCI, our work aims to directly re-form critical neural
relays across a severe injury, rather than target spared axons through grafts of OPCs; knowledge gained
from this aim could markedly improve relay formation across injury sites in the primate system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing human neural progenitor cells (hNPCs) to FDA IND approval
-
批准号:10642228
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome - Supplement
-
批准号:10876189
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2023
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10663796
-
项目类别:
-
资助金额:$112.85万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10185291
-
项目类别:
-
资助金额:$120.15万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10402369
-
项目类别:
-
资助金额:$114.19万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
ShEEP request for a Zeiss LSM 880 with Airyscan confocal system
-
批准号:9573958
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10386916
-
项目类别:
-
资助金额:$63.63万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10211059
-
项目类别:
-
资助金额:$66.34万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:10538563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:9822285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:10322642
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:10267465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:9468259
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:8804160
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8927970
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8868875
-
项目类别:
-
资助金额:$86.19万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8579707
-
项目类别:
-
资助金额:$119.42万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:9318419
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:9114022
-
项目类别:
-
资助金额:$92.55万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
GENE THERAPY FOR TREATMENT OF SPINAL CORD INJURY
-
批准号:8357236
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2011
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
海外基金